Cardiothoracic ratio, inflammation, malnutrition, and mortality in diabetes patients on maintenance hemodialysis

American Journal of the Medical Sciences

Volumn 337, Issue 6, 2009, Pages 421-428

  Yen, Tzung Hai ^a,b   Lin, Ja Liang ^a,b   Lin Tan, Dan Tzu ^a,b   Hsu, Kuang Hung ^c  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^c CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Cardiothoracic ratio; Hemodialysis; Inflammation; Malnutrition; Mortality

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; CHOLESTEROL; CREATININE; FERRITIN; TRANSFERRIN; TRIACYLGLYCEROL;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; CARDIOMEGALY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL EVALUATION; CLINICAL STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; DEMOGRAPHY; DIABETES MELLITUS; DIABETIC PATIENT; DISEASE SEVERITY; ETHICS; FEMALE; FERRITIN BLOOD LEVEL; FOLLOW UP; HEART THORAX INDEX; HEMODIALYSIS; HUMAN; INFECTION; INFLAMMATION; INFORMED CONSENT; LONGITUDINAL STUDY; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; MORTALITY; NUTRITIONAL STATUS; OUTCOME ASSESSMENT; PATIENT INFORMATION; PREDICTION AND FORECASTING; PREDICTIVE VALIDITY; PROPORTIONAL HAZARDS MODEL; SCORING SYSTEM; THORAX SURGERY; TRANSFERRIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; HEART; MIDDLE AGED; PATHOPHYSIOLOGY; RENAL REPLACEMENT THERAPY; SURVIVAL; THORAX;

DIABETES COMPLICATIONS; DIABETES MELLITUS; FEMALE; HEART; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; RENAL DIALYSIS; SURVIVAL ANALYSIS; THORAX;

EID: 67650270127     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e31819bbec1     Document Type: Article

References (50)

1. U.S. Renal Data System, USRDS. 2007 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2007.
2. Silberberg JS, Barre PE, Prichard SS, et al. Impact of left ventricular hypertrophy on survival in end-stage renal disease. Kidney Int 1989;36:286-290 (Pubitemid 19202488)
3. London GM, Pannier B, Guerin AP, et al. Alterations of left ventricular hypertrophy in and survival of patients receiving hemodialysis: follow-up of an interventional study. J Am Soc Nephrol 2001;12:2759-2767 (Pubitemid 33115424)
4. Martin LC, Franco RJ, Gavras I, et al. Association between hypervolemia and ventricular hypertrophy in hemodialysis patients. Am J Hypertens 2004;17(12 Pt 1):1163-1169 (Pubitemid 40029415)
5. Paoletti E, Specchia C, Di Maio G, et al. The worsening of left ventricular hypertrophy is the strongest predictor of sudden cardiac death in haemodialysis patients: a 10 year survey. Nephrol Dial Transplant 2004;19:1829-1834 (Pubitemid 38961395)
6. Zoccali C, Benedetto FA, Mallamaci F, et al. Left ventricular mass monitoring in the follow-up of dialysis patients: prognostic value of left ventricular hypertrophy progression. Kidney Int 2004;65:1492-1498 (Pubitemid 38406992)
7. Stack AG, Saran R. Clinical correlates and mortality impact of left ventricular hypertrophy among new ESRD patients in the United States. Am J Kidney Dis 2002;40:1202-1210 (Pubitemid 35403132)
8. Wanner C, Metzger T. C-reactive protein a marker for all-cause and cardiovascular mortality in haemodialysis patients. Nephrol Dial Transplant 2002;17(suppl 8):29-32; discussion 39-40. (Pubitemid 34918876)
9. Pupim LB, Caglar K, Hakim RM, et al. Uremic malnutrition is a predictor of death independent of inflammatory status. Kidney Int 2004;66:2054-2060
10. Kalantar-Zadeh K, Block G, Humphreys MH, et al. Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int 2003;63:793-808. (Pubitemid 36315558)
11. Lin-Tan DT, Lin JL, Wang LH, et al. Fasting glucose levels in predicting 1-year all-cause mortality in patients who do not have diabetes and are on maintenance hemodialysis. J Am Soc Nephrol 2007;18:2385-2391
12. Lin JL, Lin-Tan DT, Yen TH, et al. Blood lead levels, malnutrition, inflammation, and mortality in patients with diabetes treated by long-term hemodialysis. Am J Kidney Dis 2008;51:107-115
13. Chen KH, Lin-Tan DT, Huang WH, et al. Cardiothoracic ratio, malnutrition, inflammation, and two-year mortality in non-diabetic patients on maintenance hemodialysis. Kidney Blood Press Res 2008;31:143-151
14. Lin JL, Lin-Tan DT, Hsu KH, et al. Environmental lead exposure and progression of chronic renal diseases in patients without diabetes. N Engl J Med 2003;348:277-286
15. Sargent JA. Control of dialysis by a single-pool urea model: the National Cooperative Dialysis Study. Kidney Int Suppl 1983: S19-25.
16. Daugirdas JT. The post: pre-dialysis plasma urea nitrogen ratio to estimate K.t/V and NPCR: mathematical modeling. Int J Artif Organs 1989;12:411-419 (Pubitemid 19185306)
17. Hemingway H, Shipley M, Christie D, et al. Cardiothoracic ratio and relative heart volume as predictors of coronary heart disease mortality. The Whitehall study 25 year follow-up. Eur Heart J 1998;19:859-869
18. Poggi A, Maggiore Q. Cardiothoracic ratio as a guide to ultrafiltration therapy in dialyzed patients. Int J Artif Organs 1980;3:332-337 (Pubitemid 11162656)
19. Yeh ET, Willerson JT. Coming of age of C-reactive protein: using inflammation markers in cardiology. Circulation 2003;107:370-371
20. Centers for Disease Control and Prevention (CDC). National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey Questionnaire. Hyattsville, MD: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention. Available at: http://www.cdc.gov/ nchs/about/major/nhanes/nh3data.htm. Accessed April 17, 2009.
21. Grundy SM. Age as a risk factor: you are as old as your arteries. Am J Cardiol 1999;83:1455-7, A7.
22. Jani B, Rajkumar C. Ageing and vascular ageing. Postgrad Med J 2006;82:357-362
23. Nitta K, Akiba T, Uchida K, et al. Left ventricular hypertrophy is associated with arterial stiffness and vascular calcification in hemodialysis patients. Hypertens Res 2004;27:47-52. (Pubitemid 38208421)
24. Gusbeth-Tatomir P, Covic A. Causes and consequences of increased arterial stiffness in chronic kidney disease patients. Kidney Blood Press Res 2007;30:97-107. (Pubitemid 46674914)
25. Pecoits-Filho R, Nordfors L, Lindholm B, et al. Genetic approaches in the clinical investigation of complex disorders: malnutrition, inflammation, and atherosclerosis (MIA) as a prototype. Kidney Int Suppl 2003:S162-7. (Pubitemid 36513401)
26. Rayner BL, Goodman H, Opie LH. The chest radiograph. A useful investigation in the evaluation of hypertensive patients. Am J Hypertens 2004;17:507-510 (Pubitemid 38726165)
27. Erten Y, Tulmac M, Derici U, et al. An association between inflammatory state and left ventricular hypertrophy in hemodialysis patients. Ren Fail 2005;27:581-589 (Pubitemid 41216315)
28. Kim BS, Jeon DS, Shin MJ, et al. Persistent elevation of C-reactive protein may predict cardiac hypertrophy and dysfunction in patients maintained on hemodialysis. Am J Nephrol 2005;25:189-195
29. Yndestad A, Damas JK, Oie E, et al. Systemic inflammation in heart failure-the whys and wherefores. Heart Fail Rev 2006;11:83-92. (Pubitemid 43986210)
30. Torre-Amione G. Immune activation in chronic heart failure. Am J Cardiol 2005;95:3C-8C; discussion 38C-40C. (Pubitemid 40755512)
31. Thunberg BJ, Swamy AP, Cestero RV. Cross-sectional and longitudinal nutritional measurements in maintenance hemodialysis patients. Am J Clin Nutr 1981;34:2005-2012
32. Shah S, Davies MK, Cartwright D, et al. Management of chronic heart failure in the community: role of a hospital based open access heart failure service. Heart 2004;90:755-759 (Pubitemid 38813634)
33. Bro S, Olgaard K. Effects of excess PTH on nonclassical target organs. Am J Kidney Dis 1997;30:606-620 (Pubitemid 27465354)
34. Schluter KD, Piper HM. Cardiovascular actions of parathyroid hormone and parathyroid hormone-related peptide. Cardiovasc Res 1998;37:34-41. (Pubitemid 28122613)
35. Harnett JD, Parfrey PS, Griffiths SM, et al. Left ventricular hypertrophy in end-stage renal disease. Nephron 1988;48:107-115
36. Piovesan A, Molineri N, Casasso F, et al. Left ventricular hypertrophy in primary hyperparathyroidism. Effects of successful parathyroidectomy. Clin Endocrinol (Oxf) 1999;50:321-328
37. Kalantar-Zadeh K, Kopple JD, Regidor DL, et al. A1C and survival in maintenance hemodialysis patients. Diabetes Care 2007;30:1049-1055 (Pubitemid 46684623)
38. Oomichi T, Emoto M, Tabata T, et al. Impact of glycemic control on survival of diabetic patients on chronic regular hemodialysis: a 7-year observational study. Diabetes Care 2006;29:1496-1500 (Pubitemid 44127570)
39. Morioka T, Emoto M, Tabata T, et al. Glycemic control is a predictor of survival for diabetic patients on hemodialysis. Diabetes Care 2001;24:909-913 (Pubitemid 33636068)
40. Williams ME, Lacson E Jr, Teng M, et al. Hemodialyzed type I and type II diabetic patients in the US: characteristics, glycemic control, and survival. Kidney Int 2006;70:1503-1509 (Pubitemid 44527322)
41. Hocher B, Ziebig R, Altermann C, et al. Different impact of biomarkers as mortality predictors among diabetic and nondiabetic patients undergoing hemodialysis. J Am Soc Nephrol 2003;14:2329-2337 (Pubitemid 37052380)
42. Wu MS, Yu CC, Yang CW, et al. Poor pre-dialysis glycaemic control is a predictor of mortality in type II diabetic patients on maintenance haemodialysis. Nephrol Dial Transplant 1997;12:2105-2110
43. deFilippi C, Wasserman S, Rosanio S, et al. Cardiac troponin T and C-reactive protein for predicting prognosis, coronary atherosclerosis, and cardiomyopathy in patients undergoing long-term hemodialysis. JAMA 2003;290:353-359
44. U.S. Renal Data System, USRDS. 2006 Annual Data Report: Atlas of End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2006.
45. Schaible UE, Kaufmann SH. Malnutrition and infection: complex mechanisms and global impacts. PLoS Med 2007;4:e115.
46. Benfield T, Jensen JS, Nordestgaard BG. Influence of diabetes and hyperglycaemia on infectious disease hospitalisation and outcome. Diabetologia 2007;50:549-554 (Pubitemid 46215497)
47. Nasermoaddeli A, Miura K, Matsumori A, et al. Prognosis and prognostic factors in patients with hypertrophic cardiomyopathy in Japan: results from a nationwide study. Heart 2007;93:711-715 (Pubitemid 46808273)
48. Cohn JN, Johnson GR, Shabetai R, et al.: Ejection fraction, peak exercise oxygen consumption, cardiothoracic ratio, ventricular arrhythmias, and plasma norepinephrine as determinants of prognosis in heart failure. The V-HeFT VA Cooperative Studies Group. Circulation 1993;87(6 Suppl):VI5-16. (Pubitemid 23164217)
49. Kearney MT, Fox KA, Lee AJ, et al. Predicting sudden death in patients with mild to moderate chronic heart failure. Heart 2004;90:1137-1143 (Pubitemid 39279897)
50. Ozkahya M, Ok E, Toz H, et al. Long-term survival rates in haemodialysis patients treated with strict volume control. Nephrol Dial Transplant 2006;21:3506-3513 (Pubitemid 44817101)